Article thumbnail

Feasibility of TEE-guided stroke risk assessment in atrial fibrillation—background, aims, design and baseline data of the TIARA pilot study

By T. Dinh, L. H. B. Baur, R. Pisters, O. Kamp, F. W. A. Verheugt, J. L. R. M. Smeets, E. C. Cheriex, R. G. Tieleman, M. H. Prins and H. J. G. M. Crijns
Topics: Original Article
Publisher: Bohn Stafleu van Loghum
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
  2. (1995). Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med.
  3. and short-term temporal stability of complex fractionated atrial electrograms in human left atrium during atrial fibrillation.
  4. Aortic atheromas: current concepts and controversies-a review of the literature.
  5. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications.
  6. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
  7. (1987). Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med.
  8. Baseline characteristics of patients with atrial fibrillation:
  9. Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters.
  10. (2009). Dabigatran versus Warfarin in patients with atrial fibrillation.
  11. Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
  12. (1999). Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation.
  13. Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood.
  14. (2011). Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast
  15. Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism.
  16. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
  17. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation.
  18. (2011). Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheterdirected atrial fibrillation ablation.
  19. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo.
  20. (1994). Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med.
  21. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation.
  22. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
  23. (1992). Transesophageal echocardiography: normal variants and mimickers.
  24. Valve excrescences: prevalence, evolution and risk for cardioembolism.